While complying with local directives, Cellecta is fully operational. Normal turnaround times have not been affected by COVID-19 more >

Menu
0

While complying with local directives, Cellecta is fully operational. Normal turnaround times have not been affected by COVID-19 more >

0

Your Cart is Empty

Home / Products / SARS-CoV-2-S-D614G Pseudotyped GFP Lentivirus (titered in Cellecta HeLa-ACE2 Cells)
Cellecta SARS-CoV2-S-D614G Pseudotyped GFP Lentivirus RSCOV2-SDGG-2
Cellecta SARS-CoV2-S-D614G Pseudotyped GFP Lentivirus RSCOV2-SDGG-10
Cellecta SARS-CoV2-S-D614G Pseudotyped GFP Lentivirus RSCOV2-SDGG-50
Cellecta SARS-CoV2-S-D614G Pseudotyped GFP Lentivirus RSCOV2-SDGG-2
Cellecta SARS-CoV2-S-D614G Pseudotyped GFP Lentivirus RSCOV2-SDGG-10
Cellecta SARS-CoV2-S-D614G Pseudotyped GFP Lentivirus RSCOV2-SDGG-50

Family: Coronavirus Research and Neutralization Assays

Catalog #: RSCOV2-SDGG-2

SARS-CoV-2-S-D614G Pseudotyped GFP Lentivirus (titered in Cellecta HeLa-ACE2 Cells)

$950.00

more information on cellecta product pricing U.S. List Price more info
Prices shown reflect U.S. list pricing for orders shipped to U.S. addresses. Non-U.S. pricing may vary depending on geography. Please contact orders@cellecta.com for a quote or check our distributor page to see if Cellecta has an authorized reseller in your region.

Share or Email this Product:

Product Information

Third-generation replication-incompetent lentiviral vector expressing GFP reporter gene packaged as viral particles which are pseudotyped with the D614G SARS-CoV-2 (COVID-19) coronavirus spike glycoprotein protein variant (S-protein D614G) which recognizes and binds to the ACE2 cell surface receptor to mediate coronavirus cell entry.

This product enables investigators to run neutralization assays and related studies that investigate factors which influence spike recognition and binding to target cells in BSL-2 laboratories.

Related Items